title: RE: Clinical applications of bone morphogenetic proteins: current evidence. Kanakaris, NK; Giannoudis, PV; JSOA 17(3):133-46, 2008.
authors.forename: Tomislav
authors.initials: T
authors.lastname: Smoljanovic
authors.forename: Tomislay
authors.initials: T
authors.lastname: Smoljanovic
authors.forename: Davor
authors.initials: D
authors.lastname: Caric
authors.forename: David
authors.initials: D
authors.lastname: Caric
authors.forename: Ivan
authors.initials: I
authors.lastname: Bojanic
mesh_terms: D019485:Bone Morphogenetic Proteins / Q000009:adverse effects*; D001862:Bone Resorption / Q000139:chemically induced*; D016025:Bone Transplantation / Q000379:methods*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects*; D013123:Spinal Fusion / Q000009:adverse effects / Q000379:methods*
chemical_list: D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins